NAVINOVA
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

NAVINOVA Trademark

Serial Number: 79308794 • Registration: 6841307

NAVINOVA is a trademark filed by NAVIN FLUORINE INTERNATIONAL LIMITED on December 21, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NAVIN FLUORINE INTERNATIONAL LIMITED (4 trademarks)

2nd Floor, Sunteck Centre, 37-40,

Entity Type: 99

Trademark Details

Filing Date

December 21, 2020

Registration Date

September 13, 2022

Published for Opposition

June 28, 2022

Goods & Services

Chemical preparations used in the manufacture of medicinal products, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; chemical preparations for pharmaceuticals purposes, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder chemical preparations for medical purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; chemical preparations for pharmaceuticals purposes for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; medicinal and pharmaceutical preparations for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; chemical preparations for veterinary purposes for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; disinfectants; insecticides; germicides; pesticides; preparations for fungicides, herbicides and preparations for destroying vermin

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 3, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 14, 2022 FICS
FINAL DISPOSITION PROCESSED
Dec 14, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 13, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 13, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 13, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 28, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 28, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 8, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 18, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
May 18, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 18, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
May 18, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 18, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 13, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 13, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 13, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 27, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 27, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 27, 2022 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 11, 2022 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Dec 21, 2021 PBCR
ASSIGNED TO LIE
Dec 9, 2021 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 8, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 6, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 6, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 6, 2021 TROA
REFUSAL PROCESSED BY IB
Jul 19, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 1, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jul 1, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 22, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jun 21, 2021 CNRT
ASSIGNED TO EXAMINER
Jun 16, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 24, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 20, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 15, 2021 REPR